These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 26506388)

  • 1. Long-Term Efficacy and Safety of Repeated Intravescial OnabotulinumtoxinA Injections Plus Hydrodistention in the Treatment of Interstitial Cystitis/Bladder Pain Syndrome.
    Lee CL; Kuo HC
    Toxins (Basel); 2015 Oct; 7(10):4283-93. PubMed ID: 26506388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeated intravesical onabotulinumtoxinA injections are effective in treatment of refractory interstitial cystitis/bladder pain syndrome.
    Kuo HC
    Int J Clin Pract; 2013 May; 67(5):427-34. PubMed ID: 23574103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. O'Leary-Sant Symptom Index Predicts the Treatment Outcome for OnabotulinumtoxinA Injections for Refractory Interstitial Cystitis/Bladder Pain Syndrome.
    Kuo YC; Kuo HC
    Toxins (Basel); 2015 Jul; 7(8):2860-71. PubMed ID: 26264022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravesical botulinum toxin a injections do not benefit patients with ulcer type interstitial cystitis.
    Lee CL; Kuo HC
    Pain Physician; 2013; 16(2):109-16. PubMed ID: 23511677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeated onabotulinumtoxin-a injections provide better results than single injection in treatment of painful bladder syndrome.
    Kuo HC
    Pain Physician; 2013 Jan; 16(1):E15-23. PubMed ID: 23340540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravesical onabotulinumtoxinA injections for refractory painful bladder syndrome.
    Chung SD; Kuo YC; Kuo HC
    Pain Physician; 2012; 15(3):197-202. PubMed ID: 22622903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical evidence suggests repeated intravesical application of botulinum toxin A injections may improve treatment efficacy of interstitial cystitis/bladder pain syndrome.
    Shie JH; Liu HT; Wang YS; Kuo HC
    BJU Int; 2013 Apr; 111(4):638-46. PubMed ID: 22943596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of efficacy and safety between bladder body and trigonal intravesical onabotulinumtoxina injection in the treatment of interstitial cystitis refractory to conventional treatment-A prospective, randomized, clinical trial.
    Jiang YH; Jhang JF; Lee CL; Kuo HC
    Neurourol Urodyn; 2018 Apr; 37(4):1467-1473. PubMed ID: 29331031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of intravesical botulinum toxin type A injections plus hydrodistention with hydrodistention alone for the treatment of refractory interstitial cystitis/painful bladder syndrome.
    Kuo HC; Chancellor MB
    BJU Int; 2009 Sep; 104(5):657-61. PubMed ID: 19338543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the Clinical Efficacy and Adverse Events between Intravesical Injections of Platelet-Rich Plasma and Botulinum Toxin A for the Treatment of Interstitial Cystitis Refractory to Conventional Treatment.
    Jhang JF; Yu WR; Kuo HC
    Toxins (Basel); 2023 Feb; 15(2):. PubMed ID: 36828435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse Events of Intravesical OnabotulinumtoxinA Injection between Patients with Overactive Bladder and Interstitial Cystitis--Different Mechanisms of Action of Botox on Bladder Dysfunction?
    Kuo YC; Kuo HC
    Toxins (Basel); 2016 Mar; 8(3):. PubMed ID: 26999201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down regulation of vascular endothelial growth factor is associated with decreased inflammation after intravesical OnabotulinumtoxinA injections combined with hydrodistention for patients with interstitial cystitis--clinical results and immunohistochemistry analysis.
    Peng CH; Jhang JF; Shie JH; Kuo HC
    Urology; 2013 Dec; 82(6):1452.e1-6. PubMed ID: 24295265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravesical botulinum toxin-A injections reduce bladder pain of interstitial cystitis/bladder pain syndrome refractory to conventional treatment - A prospective, multicenter, randomized, double-blind, placebo-controlled clinical trial.
    Kuo HC; Jiang YH; Tsai YC; Kuo YC
    Neurourol Urodyn; 2016 Jun; 35(5):609-14. PubMed ID: 25914337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Prospective, Multicenter, Double-Blind, Randomized Trial of Bladder Instillation of Liposome Formulation OnabotulinumtoxinA for Interstitial Cystitis/Bladder Pain Syndrome.
    Chuang YC; Kuo HC
    J Urol; 2017 Aug; 198(2):376-382. PubMed ID: 28202358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive Factors for a Satisfactory Treatment Outcome with Intravesical Botulinum Toxin A Injection in Patients with Interstitial Cystitis/Bladder Pain Syndrome.
    Wang HJ; Yu WR; Ong HL; Kuo HC
    Toxins (Basel); 2019 Nov; 11(11):. PubMed ID: 31752328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravesical injection of botulinum toxin A for treatment of interstitial cystitis/bladder pain syndrome: 10 years of experience at a single center in China.
    Gao Y; Liao L
    Int Urogynecol J; 2015 Jul; 26(7):1021-6. PubMed ID: 25690160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Therapeutic Effect of Intratrigonal Injection of AbobotulinumtoxinA(Dysport) and Hydrodistention in Refractory Interstitial Cystitis /Bladder Pain Syndrome.
    Zargham M; Mahmoodi M; Mazdak H; Tadayon F; Mansori M; Kazemi M; Khorami MH; Saberi N
    Urol J; 2020 Nov; 18(2):203-208. PubMed ID: 33236337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intratrigonal OnabotulinumtoxinA Improves Bladder Symptoms and Quality of Life in Patients with Bladder Pain Syndrome/Interstitial Cystitis: A Pilot, Single Center, Randomized, Double-Blind, Placebo Controlled Trial.
    Pinto RA; Costa D; Morgado A; Pereira P; Charrua A; Silva J; Cruz F
    J Urol; 2018 Apr; 199(4):998-1003. PubMed ID: 29031769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent therapeutic effect of repeated injections of onabotulinum toxin a in refractory bladder pain syndrome/interstitial cystitis.
    Pinto R; Lopes T; Silva J; Silva C; Dinis P; Cruz F
    J Urol; 2013 Feb; 189(2):548-53. PubMed ID: 23253961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravesical Botulinum Toxin Injection Plus Hydrodistention Is More Effective in Patients with Bladder Pain-Predominant Interstitial Cystitis/Bladder Pain Syndrome.
    Yu WR; Jhang JF; Kuo HC
    Toxins (Basel); 2024 Feb; 16(2):. PubMed ID: 38393152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.